Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Segal Trials

Segal Trials Plays Key Role in FDA Approval of COBENFY™, A New Era in Schizophrenia Treatment
From Segal Trials
Via Business Wire
Segal Trials to Speak on Panel at Latina Expo 2024, Hosted by CISCRP, Focusing on Diversity in Clinical Research
From Segal Trials
Via Business Wire
Segal Trials Showcased Leadership in CNS Research and Psychedelic Studies at CNS Summit 2023
From Segal Trials
Via Business Wire
Segal Trials Participation in Study Shows Positive Results From Phase 3 EMERGENT-2 KarXT in Schizophrenia
From Segal Trials
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.